Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study

被引:2
作者
Lauritsen, Tine Bichel [1 ]
Ostgard, Lene Sofie Granfeldt [2 ,3 ]
Gronbaek, Kirsten [4 ,5 ]
Dalton, Susanne Oksbjerg [6 ,7 ]
Norgaard, Jan Maxwell [1 ]
机构
[1] Aarhus Univ Hosp, Dept Hematol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark
[2] Odense Univ Hosp, Dept Hematol, Odense, Denmark
[3] Aarhus Univ Hosp, Dept Clin Epidemiol, Odense, Denmark
[4] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark
[5] Univ Copenhagen, BRIC, Biotech Res & Innovat Ctr, Copenhagen, Denmark
[6] Danish Canc Soc Res Ctr, Survivorship & Inequal Canc, Copenhagen, Denmark
[7] Zealand Univ Hosp, Dept Clin Oncol & Palliat Care, Koge, Denmark
关键词
myelodysplastic syndromes; outcomes; prognosis; socioeconomic position; ACUTE MYELOID-LEUKEMIA; HEALTH-CARE-SYSTEM; CANCER INFLUENCE; SURVIVAL; COMORBIDITY; INCOME; STAGE; EDUCATION; DISEASE; IMPACT;
D O I
10.1002/hon.3068
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population-based cohort study (2010-2018) of 2233 Danish patients with MDS. SEP measures included individual-level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time-to-event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo-HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion-dependent at diagnosis (RR = 1.25, 95% CI: 1.04-1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03-1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1-year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08-1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14-1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98-1.35). These associations persisted after 3 years and 5 years of follow-up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo-HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31-0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS.
引用
收藏
页码:1056 / 1066
页数:11
相关论文
共 34 条
[1]   Pseudo-observations in survival analysis [J].
Andersen, Per Kragh ;
Perme, Maja Pohar .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2010, 19 (01) :71-99
[2]  
[Anonymous], DANISH TRANSFUSION D
[3]  
[Anonymous], Statistics denmark
[4]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[5]   Danish registers on personal income and transfer payments [J].
Baadsgaard, Mikkel ;
Quitzau, Jarl .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :103-105
[6]   Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register [J].
Berggren, Daniel Moreno ;
Folkvaljon, Yasin ;
Engvall, Marie ;
Sundberg, Johan ;
Lambe, Mats ;
Antunovic, Petar ;
Garelius, Hege ;
Lorenz, Fryderyk ;
Nilsson, Lars ;
Rasmussen, Bengt ;
Lehmann, Soren ;
Hellstrom-Lindberg, Eva ;
Jadersten, Martin ;
Ejerblad, Elisabeth .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) :614-627
[7]   Socioeconomic status in health research - One size does not fit all [J].
Braveman, PA ;
Cubbin, C ;
Egerter, S ;
Chideya, S ;
Marchi, KS ;
Metzler, M ;
Posner, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22) :2879-2888
[8]   Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010 [J].
Dalton, Susanne O. ;
Steding-Jesen, Marianne ;
Jakobsen, Erik ;
Mellemgaard, Anders ;
Osterlind, Kell ;
Schuz, Joachim ;
Johansen, Christoffer .
ACTA ONCOLOGICA, 2015, 54 (05) :797-804
[9]   Socioeconomic inequality in cancer survival - changes over time. A population-based study, Denmark, 1987-2013 [J].
Dalton, Susanne Oksbjerg ;
Olsen, Maja Halgren ;
Johansen, Christoffer ;
Olsen, Jurgen H. ;
Andersen, Kaae Klaus .
ACTA ONCOLOGICA, 2019, 58 (05) :737-744
[10]   Income and outcome in myelodysplastic syndrome: The prognostic impact of SES in a single-payer system [J].
England, James T. ;
Zhang, Liying ;
Buckstein, Rena ;
Lenis, Martha ;
Li, Claudia ;
Earle, Craig ;
Wells, Richard A. .
LEUKEMIA RESEARCH, 2013, 37 (11) :1495-1501